Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications

Authors:
  • CCChristoph U. Correll
    Christoph U. Correll
  • EKElisse Kramer-Ginsberg
    Elisse Kramer-Ginsberg
  • NANasreen Abdulhamid
    Nasreen Abdulhamid
  • FKFiju Koshy
    Fiju Koshy
  • ERElayna Rubens
    Elayna Rubens
  • RSRobert Saint-Vil
    Robert Saint-Vil
  • JKJohn M. Kane
    John M. Kane
  • PMPeter Manu
    Peter Manu

Abstract
OBJECTIVE: Despite concerns about the adverse effects of second-generation antipsychotics on weight regulation and glucose and lipid metabolism, little is known about the relationship between these agents and the metabolic syndrome. Because the metabolic syndrome is more strongly associated with cardiovascular morbidity and mortality than its individual components, attention to the full syndrome is important. The authors’ goal was to explore the relationship between second-generation antipsychotics and the metabolic syndrome. METHOD: They assessed the prevalence of metabolic syndrome in a nearly consecutive group of 89 acutely admitted psychiatric inpatients treated with at least one second-generation antipsychotic for different psychiatric disorders. Patients’ waist circumference and blood pressure were measured as well as their fasting blood glucose and lipid levels. RESULTS: Twenty-six (29.2%) of the 89 patients fulfilled criteria for the metabolic syndrome. Presence of the syndrome was associated with...

This publication has 25 references indexed in Scilit: